Reduced DNA-dependent protein kinase activity is associated with lung cancer

Carcinogenesis

Volumn 22, Issue 5, 2001, Pages 723-727

  Auckley, Dennis H ^a,d   Crowell, Richard E ^a   Heaphy, Evelyn R ^a   Stidley, Christine A ^b   Lechner, John F ^c,e   Gilliland, Frank D ^b,f   Belinsky, Steven A ^c  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^d METROHEALTH MEDICAL CENTER   (United States)

^e BAYER CORPORATION   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARCINOGEN; DNA DEPENDENT PROTEIN KINASE; DOUBLE STRANDED DNA; PROTEIN SERINE THREONINE KINASE;

ADULT; AGED; ARTICLE; BRONCHUS MUCOSA; CANCER RISK; CANCER SUSCEPTIBILITY; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA RECOMBINATION; DNA REPAIR; DNA STRAND BREAKAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; LUNG CANCER; MALE; MONONUCLEAR CELL; POPULATION; PRIORITY JOURNAL; STEM CELL; TRANSCRIPTION REGULATION;

EID: 0035026565     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.5.723     Document Type: Article

References (33)

1. American Cancer Society (1997) Cancer Facts and Figures. The American Cancer Society, Atlanta, GA.
2. Vogel, F., Buselmaier, W., Reidert, W., Kellerman, G. and Berg, P. (1978) Human genetic variation in response to medical and environmental agents: pharmacogenetics and ecogenetics. Hum. Genet., 1 (suppl.), 1-192.
3. Mattson, M.E., Pollack, E.S. and Cullen, J.W. (1987) What are the odds that smoking will kill you? Am. J. Publ. Health, 77, 425-431.
4. Raunio, H., Husgafvel-Pursiainen, K., Anttila, S., Hietanen, E., Hirvonen, A. and Pelkonen, O. (1995) Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility: a review. Gene, 159, 113-121.
5. Wei, Q., Cheng, L., Hong, W.K. and Spitz, M.R. (1996) Reduced DNA repair capacity in lung cancer patients. Cancer Res., 56, 4103-4107.
6. Spitz, M.R., Hsu, T.C., Wu, X., Fueger, J.J., Amos, C.I. and Roth, J.A. (1995) Mutagen sensitivity as a biological marker of lung cancer risk in African-Americans. Cancer Epidemiol. Biomarkers Prev., 4, 99-103.
7. Shen, M.R., Jones, I.M. and Mohreweiser, H. (1998) Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res., 58, 604-608.
8. Lunn, R.M., Langlois, R.G., Hsieh, L.L., Thompson, C.T. and Bell, D.A. (1999) XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res., 58, 604-608.
9. Divine, K.K., Gilliland, F.D., Crowell, R.E., Stidley, C.A., Bocklage, T.J., Cook, D.L. and Belinsky, S.A. (2001) The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. Mutat. Res., 461, 273-278.
10. Lees-Miller, S.P. (1996) The DNA-dependent protein kinase, DNA-PK: 10 years and no ends in sight. Biochem. Cell Biol., 74, 503-512.
11. Suwa, A., Hirakata, M., Takeda, Y., Jersch, S.A., Mimori, T. and Hardin, J.A. (1994) DNA-dependent protein kinase (Ku protein-p350 complex) assembles on double strand-DNA. Proc. Natl Acad. Sci. USA, 91, 6904-6908.
12. Critchlow, S.E., Bowater, R.P. and Jackson, S.P. (1997) Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV. Curr. Biol., 7, 588-598.
13. Lees-Miller, S., Sakaguchi, K., Ullrich, S., Apella, E. and Anderson, C. (1992) Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino terminal transactivation domain of human p53. Mol. Cell. Biol., 12, 5041-5049.
14. Jeggo, P.A. (1997) DNA-PK: at the cross-roads of biochemistry and genetics. Mutat. Res., 384, 1-14.
15. Lees-Miller, S.P., Godbout, R., Chan, D.W., Weinfeld, M., Day, R.S., Barron, G.M. and Allalunis-Tumer, J. (1995) Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science, 267, 1183-1185.
16. Getts, R.C. and Stamato, T.D. (1994) Absence of a Ku-like DNA end binding activity in the xrs double-strand DNA repair-deficient mutant. J. Biol. Chem., 269, 15981-15984.
17. Ajmani, A.K., Satoh, M., Reap, E., Cohen, P.L. and Reeves, W.H. (1995) Absence of autoantigen Ku in mature human neutrophils and promyelocytic leukemia line (HL-60) cells and lymphocytes undergoing apoptosis. J. Exp. Med., 181, 2049-2058.
18. Crowell, R.E., Gilliland, F.D., Temes, R.T., Harms, H.J., Neft, R.E., Heaphy, E.R., Auckley, D.H., Crooks, L.A., Jordan, S.W., Samet, J.M., Lechner, J.E and Belinsky, S.A. (1996) Detection of trisomy 7 in non-malignant bronchia! epithelium from lung cancer patients and individuals at risk for lung cancer. Cancer Epidemiol. Biomarkers Prev., 5, 631-637.
19. Anderson, C. and Lees-Miller, S. (1992) The nuclear serine/threonine protein kinase DNA-PK. Crit. Rev. Eukaryot. Gene Expr., 2, 283-314.
20. Lechner, J.F. and Kaighn, M.E. (1985) Application of the principles of enzyme kinetics to clonal growth rate assays: an approach for delineating interactions among growth promoting agents. J. Cell. Physiol., 100, 519-529.
21. Kuo, M.T. and Hsu, T.C. (1978) Bleomycin causes release of nucleosomes from chromatin and chromosomes. Nature (Lond.), 271, 83-84.
22. Muller, C., Dusseau, C., Calsou, P. and Salles, B. (1998) Human normal peripheral blood B-lymphocytes are deficient in DNA-dependent protein kinase activity due to the expression of a variant form of the Ku86 protein. Oncogene, 16, 1553-1560.
23. Fracchia, A., Pacetti, M., Barberis, M., Mura, M.A., Le Grazie, C. and Longhini, E. (1987) Determination of T-lymphocyte subpopulations in patients with lung cancer. Respiration, 51, 161-169.
24. Ginns, L.L., Goldenheim, P.P., Miller, L.G., Burton, R.C., Gillick, L., Colvin, R.B., Goldstein, G., Kung, P.L., Hurwitz, C. and Kazemi, H. (1982) T-lymphocyte subsets in smoking and lung cancer. Am. Rev. Respir. Dis., 126, 265-269.
25. Wiencki, J.K., Spitz, M.R., McMillan, A. and Kelsey, K.T. (1997) Lung cancer in Mexican-Americans and African Americans is associated with the wild-type genotype of the NAD(P)H:quinone oxidoreductase polymorphism. Cancer Epidemiol. Biomarkers Prev., 6, 87-92.
26. Cascorbi, I., Brockmoller, J., Przemyslaw, M.M. Bauer, S., Loddenkemper, R. and Roots, I. (1996) Homozygous rapid arylamine N-acetyltransferase (NAT-2) genotype as a susceptibility factor for lung cancer. Cancer Res., 56, 3961-3966.
27. Helbig, R., Zdziencka, M.Z. and Speit, G. (1995) The effect of defective DNA double-strand break repair on mutations and chromosomal aberration in the Chinese hamster cell mutant XR-V15B. Radial. Res., 143, 151-157.
28. Natarajan, A.T., Darroudi, F., Mullenders, L.H. and Meijers, M. (1986) The nature and repair of DNA lesions that lead to chromosomal aberrations induced by ionizing radiation. Mutat. Res., 160, 231-236.
29. Okayasu, R., Suetomi, K., Yu, Y., Silver, A., Bedford, J.S., Cox, R. and Ullrich, R.L. (2000) A deficiency in DNA repair and DNA-PKcs expression in the radiosensitive BALB/c mouse. Cancer Res., 60, 4342-4345.
30. Luo, C., Tang, W., Mekeel, K.L., Defrank, J.S., Anne, P.R. and Powell, S.N. (1996) High frequency and effort prone DNA recombination in ataxia telangiectasia cell lines. J. Biol. Chem., 271, 4497-4503.
31. Zabain, V.A. (1995) ATM-related genes: what do they tell us about functions of the human gene. Cell, 82, 685-687.
32. Wu, X.F., Spitz, M.R., Delclos, G.L., Connor, T.H., Zhao, Y., Siciliano, M.J. and Hsu, T.C. (1996) Survival of cells with bleomycin-induced chromosomal lesions in the cultured lymphocytes of lung cancer patients. Cancer Epidemiol. Biomarkers Prev., 5, 527-532.
33. Lubin, J.H., Boice, J.D. Jr, Edling, C., Hornung, R.W., Howe, G.K., Kunz, E., Kusiak, R.A., Morrison, H.I., Radford, E.P., Samet, J.M., Tirmarche, M., Woodward, A., Yao, S.X. and Pierce, D.A. (1995) Lung cancer among radon-exposed miners and estimation of risk from indoor exposure. J. Natl Cancer Inst., 87, 817-827.